In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...

The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

Many engineering challenges come down to the same headache—too many knobs to turn and too few chances to test them. Whether tuning a power grid or designing a safer vehicle, each evaluation can be ...

Artificial intelligence can solve problems at remarkable speed, but it's the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists ...

A new study introduces a global probabilistic forecasting model that predicts when and where ionospheric disturbances—measured by the Rate of total electron content (TEC) Index (ROTI)—are likely to ...

Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...